Preclinical Study Links Gene to Brain Aneurysm FormationAugust 08, 2007CINCINNATI-University of Cincinnati (UC) neurovascular researchers have identified a gene that-when suppressed or completely absent-may predispose a person to brain aneurysms. Todd Abruzzo, MD, and his colleagues demonstrated that "knocking out" a gene known as endothelial nitric oxide synthase (NOS-3) in an animal model led to intracranial aneurysm formation in 33 percent of study subjects. Scientists say this suggests that the gene may play an important role in the development of intracranial aneurysms.
An aneurysm occurs when a blood vessel weakens and stretches, forming a bulge in the vessel wall that can rupture and hemorrhage. Intracranial arterial aneurysms are bulges that develop in the arteries that carry blood to the brain. Previous studies have shown that variants of the NOS-3 gene are markers for vascular disease. The gene also plays an important role in remodeling of blood vessels in response to changes in blood flow. "When a vessel experiences increased blood flow, it attempts to reduce the shear stress to even levels by enlarging its luminal caliber through a process known as remodeling. This involves reabsorbing the inner layers of the vessel wall and forming new outer layers to replace them," explains Abruzzo. "Although we don't fully understand the genetic determinants that control an individual's susceptibility to aneurysm formation," he adds, "this study is an important clue because it links a known gene with a known function to an increased risk for intracranial aneurysm formation." Abruzzo says this study supports the idea that the NOS-3 gene is just one step in a complex molecular pathway that links flow-dependent vascular remodeling to intracranial aneurysm formation. "Our findings suggest that if something goes wrong in the vascular remodeling process, it could trigger formation of an aneurysm," he adds. Abruzzo reports these findings in the August 2007 issue of Current Neurovascular Research. The UC-led team analyzed 30 female mice bred to suppress (knock out) one of three genes and molecular pathways associated with vascular disease: inducible nitric oxide synthase (NOS-2), endothelial nitric oxide synthase (NOS-3) or the plasminogen activator inhibitor (PAI-1). To determine whether absence of the genes resulted in an increased rate of aneurysm formation, researchers blocked one of the two carotid arteries that carry blood to the brain. They then examined brain artery samples for signs of aneurysm formation. The researchers found no indications of aneurysm formation in the PAI-1, NOS-2 or wild type control groups. Mice with the NOS-3 knock out, however, formed intracranial aneurysms. Collaborators in the study include UC's Ady Kendler, PhD, and Jane Khoury, PhD, Michael Workman, of Springfield Neurological and Spine Institute, Harry Cloft, MD, of Mayo Clinic and the late Robert Apkarian, PhD, of Emory University. Abruzzo is affiliated with the Neuroscience Institute at UC and University Hospital, a center of excellence that focuses on the main diseases of the brain and nerves such as stroke, brain tumors, brain trauma, Parkinson's and Alzheimer's disease, epilepsy, ALS and multiple sclerosis. University of Cincinnati | |||||||||||||||||||||
|
Related Aneurysm Current Events and Aneurysm News Articles Routine Testing After Aneurysm Coiling Carries Low Risk A very low risk of complication is associated with a routine test that determines whether a brain aneurysm treated with endovascular coiling has started to recur, a study led by the University of Cincinnati Neuroscience Institute has shown. Yale researchers unravel mystery of brain aneurysms Yale researchers have taken the first critical steps in unraveling the mysteries of brain aneurysms, the often fatal rupturing of blood vessels that afflicts 500,000 people worldwide each year and nearly killed Vice President-elect Joseph Biden two decades ago. Tiny 3-D ultrasound probe guides catheter procedures An ultrasound probe small enough to ride along at the tip of a catheter can provide physicians with clearer real-time images of soft tissue without the risks associated with conventional x-ray catheter guidance. NYC first: Complex aneurysm treated using new fenestrated endograft stent In a New York City metro-area first, a 93-year-old Bronx man underwent implantation of a new stent graft at NewYork-Presbyterian Hospital, the only center on the Eastern Seaboard with access to this investigational device. Will screening for aortic aneurysm be effective? Pilot screening programmes for abdominal aortic aneurysms in men aged 65 are due to be launched in England this year, but is this move too hasty? Two experts debate the issue in this week's BMJ. MRI better than MDCT in detecting endoleaks, study says Contrast-enhanced MR imaging is significantly superior to 16 slice multidetector CT in the detection of endoleaks after endovascular repair of abdominal aortic aneurisms (EVAR), according to a recent study conducted by researchers at Ospedale San Giovanni in Bellinzona, Switzerland. Smokers treated for brain aneurysm with coils at higher risk of recurrence Cigarette smokers who were treated for cerebral aneurysms with coil embolization (blocking of a blood vessel) are at greater risk of developing another aneurysm, say neurological surgeons at Jefferson Hospital for Neuroscience in Philadelphia in the first-known study of its kind. A strange case of upper obstructive syndrome Aorto-duodenal fistulae (ADF) are the most frequent aorto-enteric fistulae (80%) and the most frequent presenting sign of ADF is upper gastrointestinal bleeding (UGI). UC study: New devices less effective in thwarting brain aneurysm recurrence A retrospective analysis of 100 patients suffering from a ruptured brain aneurysm has found that expensive new coiling devices are no more effective than bare platinum coils at preventing aneurysms from recurring. Study Finds Half of Patients Undergoing Cerebrovascular Stent Placement Respond Poorly to the Antiplatelet Drug Clopidogrel (Plavix) A study by researchers at Rush University Medical Center, published in the February issue of the American Journal of Neuroradiology, finds that half of patients undergoing cerebrovascular stent placement did not respond well to clopidogrel. Clopidogrel (Plavix) and aspirin are medications routinely prescribed for 1-3 months following cerebrovascular stent placement to combat the risk of blood clots (stent-thrombosis) and reclosure of the artery (re-stenosis). More Aneurysm Current Events and Aneurysm News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||